Page 1 of Clinical Trials for Copolymer 1, 87 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
Last Updated: April 13, 2011
Condition(s): Relapsing Remitting Multiple Sclerosis
2
Completed
Treatment of Multiple Sclerosis With Copaxone and Albuterol
Last Updated: May 7, 2012
Condition(s): Autoimmune Diseases; Multiple Sclerosis
3
Active, not recruiting
Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis
Last Updated: May 3, 2012
Condition(s): Multiple Sclerosis
4
Completed
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
Last Updated: April 11, 2011
Condition(s): Relapse Remitting Multiple Sclerosis
5
Completed
Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
Last Updated: August 22, 2011
Condition(s): Multiple Sclerosis
6
Active, not recruiting
Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation
Last Updated: May 13, 2008
Condition(s): Diabetic Retinopathy
7
Completed
Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
Last Updated: October 6, 2011
Condition(s): Relapsing Remitting Multiple Sclerosis
8
Recruiting
Efficacy and Safety of GTR in Comparison to Copaxone®
Last Updated: April 20, 2012
Condition(s): Multiple Sclerosis
9
Completed
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.
Last Updated: April 7, 2011
Condition(s): Multiple Sclerosis
10
Completed
A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose
Last Updated: January 12, 2010
Condition(s): Relapse-Remitting Multiple Sclerosis
11
Recruiting
A Double Blinded, Placebo Controlled, Randomized Study Comparing Rituximab Induction Therapy Followed by Glatiramer Acetate Therapy to Glatiramer Acetate Monotherapy in Patients With Relapsing Forms of Multiple Sclerosis
Last Updated: April 2, 2012
Condition(s): Multiple Sclerosis
12
Completed
A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®
Last Updated: April 16, 2009
Condition(s): Multiple Sclerosis
13
Active, not recruiting
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Last Updated: February 24, 2012
Condition(s): Multiple Sclerosis
14
Recruiting
Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)
Last Updated: February 9, 2010
Condition(s): Multiple Sclerosis
15
Completed
Safety of New Formulation of Glatiramer Acetate
Last Updated: May 10, 2011
Condition(s): Relapsing Remitting Multiple Sclerosis
16
Completed
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
Last Updated: September 6, 2011
Condition(s): Multiple Sclerosis
17
Recruiting
To Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With RRMS
Last Updated: May 17, 2012
Condition(s): Relapsing-Remitting Multiple Sclerosis
18
Recruiting
A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease
Last Updated: March 1, 2009
Condition(s): Crohns Disease
19
Completed
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.
Last Updated: April 7, 2011
Condition(s): Multiple Sclerosis
20
Completed
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
Last Updated: August 22, 2011
Condition(s): Optic Neuritis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Copolymer+1

Page 1 of Clinical Trials for Copolymer 1, 87 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About